SIH Partners’s Sana Biotechnology SANA Stock Holding History

SIH Partners’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,427	Closed	-$22.6K	–	285
2025 Q1	$22.6K	Buy	+13,427	New	+$37.5K	﹤0.01%	262

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIH Partners's SANA Position: Q2 2025 in Review

SIH Partners sold out of Sana Biotechnology (SANA) in Q2 2025, closing a stake of 13,427 shares — an estimated $22.6K sold.

SIH Partners first reported a position in SANA in Q1 2025 and held it in 1 quarter. The position peaked at $22.6K in Q1 2025. 155 funds tracked by Wall St. Rank hold SANA as of Q2 2025.

SIH Partners reported no remaining Sana Biotechnology position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 13,427 Sana Biotechnology shares in Q2 2025, an estimated $22.6K.
SIH Partners first reported a position in Sana Biotechnology in Q1 2025 and held it in 1 quarter.
SIH Partners's Sana Biotechnology position peaked at $22.6K in Q1 2025.
155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.